| |
Efficiency & productivity in biologics manufacturing is a longstanding goal, as increasingly complex molecules transform approaches to drug development. Process intensification, with advanced techniques & high productivity platforms, accelerates this pace of innovation. Read white paper. .png)
|
|
Today's Big NewsJul 26, 2023 |
|
Thursday, August 3, 2023 | 11am ET / 8am PT Join us for this insightful discussion on how to unlock the full potential of liquid biopsy and be an integral part of the future of precision medicine. We’ll take a deep dive into the latest strategies and solutions designed to help overcome current challenges and empower researchers and clinicians with enhanced capabilities. Register now. 
|
|
| By Annalee Armstrong Analysts and investors wanted the tea on the FDA review of Sage Therapeutics’ zuranolone, but Biogen CEO Chris Viehbacher wouldn’t spill it. |
|
|
|
| Philadelphia, PA |  |
|
|
By Angus Liu Following in EU regulators' footsteps, the U.K. has reportedly launched a probe into potential suicide risks for popular diabetes and weight-loss drugs. |
By James Waldron The first two European Big Pharmas to announce their second-quarter earnings have both given a glimpse into how the Inflation Reduction Act is already impacting their R&D decision-making. |
By Andrea Park Freefalling demand for COVID-19 tests may still be a headwind on Quest Diagnostics’ overall earnings, but with that removed from the equation, it’s much smoother sailing for the testmaker. |
|
Wednesday, September 6, 2023 | 2:00 PM ET / 11:00 AM PT Attendees will learn about tools for interacting with medical images, guiding readers through labeling workflows, and streamlining adjudication and data standardization. Real-world use cases of how pharma companies are enhancing AI development by optimizing reader workflows will be discussed. Register now. 
|
|
By Angus Liu Despite a positive opinion from local drug reviewers, GSK has decided not to bring its FDA-approved oral anemia drug daprodustat to Europe—or any additional countries for that matter. |
By Conor Hale The agreement includes $600 million in upfront cash, plus $50 million tied to the completion of future commercial milestones. |
By Nick Paul Taylor Suddenly, protracted soccer transfer sagas are the least of Joe Lewis’ worries. The Department of Justice has leveled a raft of accusations at the billionaire owner of a Premier League club, who stands accused of conspiring to defraud Mirati Therapeutics and insider trading in Solid Biosciences. |
By Joseph Keenan Biovian, a Finnish CDMO, earmarked €50 million ($55 million) to expand its advanced therapy manufacturing operations in Turku, Finland. |
By Andrea Park A new technology currently under development by Glucotrack aims to hugely cut down on the upkeep required for current CGM systems—potentially quadrupling the lifespan of the current longest-lasting device. |
By James Waldron With hopes of a merger with MEI Pharma now sunk for good, Infinity Pharmaceuticals is jettisoning three-quarters of its staff and three board members to stay afloat while it scans the horizon for another financial life raft. |
Fierce podcasts Don't miss an episode |
| This week on "Podnosis," we take a deep dive into the OTC approval of Narcan, the opioid overdose drug. |
|
|---|
|
|
|
Thursday, August 17, 2023 | 11am ET / 8am PT In this webinar, we will discuss the challenges and opportunities for WGBS in an era of cost-effective sequencing: Optimizing protocols and reagents for consistent and reliable results, establishing community standards to ensure WGBS library quality, and more. Register now.
|
|
Webinar Download this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
Whitepaper Learn more about the current challenges and issues that eClinical technology providers are facing. Sponsored by: YPrime |
Research The right sourcing strategy can help save of millions of dollars—learn about developing a strategy for sourcing the cGMP chemicals critical to your processes. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
Whitepaper Learn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
eBook This eBook identifies the trends driving major change in the Medical Affairs (MA) function. It also outlines the strategic and tactical implications for MA leaders and team members. Sponsored by: Blue Matter, strategic consultants in the life sciences |
eBook Take a look at the reporting tools sponsors need to access insights earlier in the clinical trial enrollment funnel, so you can take informed actions. Sponsored by: OneStudyTeam |
Whitepaper Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your bioprocessing workflows. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
| |
|
